Cvs Pharmacy #10229 - Medicare Supplier in Avondale, AZ

Cvs Pharmacy #10229 is a medicare enrolled Community/Retail Pharmacy in Avondale, Arizona. It is located at 280 N Avondale Blvd, Avondale, Arizona 85323. You can reach out to the office of Cvs Pharmacy #10229 via phone at (623) 882-2021. Cvs Pharmacy #10229 supplies medicare equipments and products such as Enteral Nutrients, Enteral Equipment and/or Supplies, Commodes, Urinals, & Bedpans, Canes & Crutches, Blood Glucose Monitors & Supplies: Non-Mail Order, Blood Glucose Monitors & Supplies: Mail Order, etc. The legal business name for Cvs Pharmacy #10229 is German Dobson Cvs Llc.

Contact Information

Cvs Pharmacy #10229
280 N Avondale Blvd, Avondale, Arizona 85323
(623) 882-2021


Supplier Profile

NameCvs Pharmacy #10229
Organization NameGerman Dobson Cvs Llc
Location280 N Avondale Blvd, Avondale, Arizona 85323
TypeCommunity/Retail Pharmacy
Phone(623) 882-2021
Participate in MedicareMedicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier.

News Archive

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.

Study determines safest temperature and duration for body-cooling of newborns

After more than 20 years of research on the best treatment for full-term infants affected by oxygen deprivation during the birthing process, Seetha Shankaran, M.D., neonatologist at DMC's Children's Hospital of Michigan and Hutzel Women's Hospital, served as the lead investigator in a definitive Journal of the American Medical Association study that documented the safest depth and duration of body-cooling to minimize injury from hypoxic ischemic encephalopathy (HIE) in newborns.

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.

Study may lead to personalized treatments for cystic fibrosis

Some 2,103 mutations have been identified in patients with cystic fibrosis (CF), the most common fatal genetic disease in Canada, and together they pose huge challenges for patients and researchers, including those affiliated with Université de Montreal and its teaching hospital, the Centre hospitalier de l'Université de Montréal (CHUM).

Read more Medical News

› Verified 2 days ago

Products, Equipments, Supplies available at this Supplier:

Cvs Pharmacy #10229 supplies following medicare products, supplies and equipments -
  • Blood Glucose Monitors & Supplies: Mail Order
  • Blood Glucose Monitors & Supplies: Non-Mail Order
  • Canes & Crutches
  • Commodes, Urinals, & Bedpans
  • Enteral Equipment and/or Supplies
  • Enteral Nutrients
  • Heat & Cold Applications
  • Nebulizer Equipment & Supplies
  • Ostomy Supplies
  • Parenteral Equipment and/or Supplies
  • Parenteral Nutrients
  • Surgical Dressings
  • Urological Supplies
  • Walkers

NPI Associated with this Supplier:

Suppliers may have multiple NPI numbers. We have found possible NPI number/s associated with Cvs Pharmacy #10229 from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1073039061
TypeCommunity/Retail Pharmacy
Address280 N Avondale Blvd, Avondale, AZ 85323
Phone Number623-882-2021

News Archive

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.

Study determines safest temperature and duration for body-cooling of newborns

After more than 20 years of research on the best treatment for full-term infants affected by oxygen deprivation during the birthing process, Seetha Shankaran, M.D., neonatologist at DMC's Children's Hospital of Michigan and Hutzel Women's Hospital, served as the lead investigator in a definitive Journal of the American Medical Association study that documented the safest depth and duration of body-cooling to minimize injury from hypoxic ischemic encephalopathy (HIE) in newborns.

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.

Study may lead to personalized treatments for cystic fibrosis

Some 2,103 mutations have been identified in patients with cystic fibrosis (CF), the most common fatal genetic disease in Canada, and together they pose huge challenges for patients and researchers, including those affiliated with Université de Montreal and its teaching hospital, the Centre hospitalier de l'Université de Montréal (CHUM).

Read more Medical News

› Verified 2 days ago


NPI Number1811303332
Organization NameGERMAN DOBSON CVS LLC
Doing Business AsCVS PHARMACY #10229
TypeDurable Medical Equipment & Medical Supplies Supplier
Address280 N Avondale Blvd, Avondale, AZ 85323
Phone Number623-882-2021

News Archive

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.

Study determines safest temperature and duration for body-cooling of newborns

After more than 20 years of research on the best treatment for full-term infants affected by oxygen deprivation during the birthing process, Seetha Shankaran, M.D., neonatologist at DMC's Children's Hospital of Michigan and Hutzel Women's Hospital, served as the lead investigator in a definitive Journal of the American Medical Association study that documented the safest depth and duration of body-cooling to minimize injury from hypoxic ischemic encephalopathy (HIE) in newborns.

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.

Study may lead to personalized treatments for cystic fibrosis

Some 2,103 mutations have been identified in patients with cystic fibrosis (CF), the most common fatal genetic disease in Canada, and together they pose huge challenges for patients and researchers, including those affiliated with Université de Montreal and its teaching hospital, the Centre hospitalier de l'Université de Montréal (CHUM).

Read more Medical News

› Verified 2 days ago

News Archive

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.

Study determines safest temperature and duration for body-cooling of newborns

After more than 20 years of research on the best treatment for full-term infants affected by oxygen deprivation during the birthing process, Seetha Shankaran, M.D., neonatologist at DMC's Children's Hospital of Michigan and Hutzel Women's Hospital, served as the lead investigator in a definitive Journal of the American Medical Association study that documented the safest depth and duration of body-cooling to minimize injury from hypoxic ischemic encephalopathy (HIE) in newborns.

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.

Study may lead to personalized treatments for cystic fibrosis

Some 2,103 mutations have been identified in patients with cystic fibrosis (CF), the most common fatal genetic disease in Canada, and together they pose huge challenges for patients and researchers, including those affiliated with Université de Montreal and its teaching hospital, the Centre hospitalier de l'Université de Montréal (CHUM).

Read more News

› Verified 2 days ago


Suppliers in Avondale, AZ

Cvs Pharmacy #10229
Type: Community/Retail Pharmacy
Location: 280 N Avondale Blvd, Avondale, Arizona 85323
Phone: (623) 882-2021    
Walgreens #3387
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 10705 W Indian School Rd, Avondale, Arizona 85392
Phone: (623) 877-3245    
Walgreens #7387
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 10710 W Mcdowell Rd, Avondale, Arizona 85392
Phone: (623) 936-7234    
Walmart Pharmacy 10-2554
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 13055 W Rancho Santa Fe Blvd, Avondale, Arizona 85392
Phone: (623) 935-4022    
Sams Pharmacy 104830
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 1459 N Dysart Rd, Avondale, Arizona 85323
Phone: (623) 882-3871    

Medicare Suppliers

Durable Medical Equipment & Medical Supplies

Also referred to as DME Suppliers. A supplier of medical equipment such as respirators, wheelchairs, home dialysis systems, or monitoring systems, that are prescribed by a physician for a patient's use in the home and that are usable for an extended period of time.

Community/Retail Pharmacy

A pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers; administer vaccinations; and provide other professional services associated with pharmaceutical care.

Prosthetic/Orthotic Supplier

An organization that provides prosthetic and orthotic care which may include, but is not limited to, patient evaluation, prosthesis or orthosis design, fabrication, fitting and modification to treat limb loss for purposes of restoring physiological function and/or cosmesis or to treat a neuromusculoskeletal disorder or acquired condition.


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.